PBH

Prestige Consumer Healthcare Inc.
$47.80
-1.66 (-3.36%)
Mkt Cap 2.26B
Volume 529,440
52W Range 42.62-71.07
Sector Healthcare
Beta 0.34
EPS (TTM) 3.59 USD
P/E Ratio 13.31
Revenue (TTM) 1.10B USD
Rev Growth (5Y) +2.9%
EPS Growth (5Y) +3.7%
AlphaVal · Fair Value
What we estimate one share is worth
$54.74
Fair Value weak signal
12.7% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
C+
Stable Earnings Power
61.1 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 1.09B 1.14B 1.13B 1.13B 1.09B 943.37M 963.01M 975.78M 1.04B 882.06M 806.25M 714.62M
Net Income 190.30M 214.60M 209.34M (82.31M) 205.38M 164.68M 142.28M (35.80M) 339.57M 69.39M 99.91M 78.26M
EPS 3.93 4.32 4.21 -1.65 4.09 3.28 2.81 -0.69 6.34 1.31 1.89 1.50
Free Cash Flow 246.45M 243.29M 239.38M 221.93M 250.28M 213.36M 202.56M 178.80M 197.58M 144.79M 170.78M 150.15M
FCF / Share 5.09 4.90 4.81 4.45 4.98 4.25 3.99 3.45 3.72 2.73 3.24 2.88
Operating CF 257.63M 251.51M 248.93M 229.72M 259.92M 235.61M 217.12M 189.28M 210.11M 147.77M 174.35M 156.25M
Total Assets 3.55B 3.40B 3.32B 3.35B 3.67B 3.43B 3.51B 3.44B 3.76B 3.91B 2.95B 2.67B
Total Debt 1.05B 1.04B 1.14B 1.37B 1.51B 1.51B 1.77B 1.80B 1.99B 2.19B 1.63B 1.59B
Cash & Equiv 63.87M 97.88M 46.47M 58.49M 27.18M 32.30M 94.76M 27.53M 32.55M 41.85M 27.23M 21.32M
Book Value 1.89B 1.83B 1.66B 1.45B 1.58B 1.36B 1.17B 1.10B 1.18B 822.55M 744.34M 627.62M
Return on Equity 0.10 0.12 0.13 -0.06 0.13 0.12 0.12 -0.03 0.29 0.08 0.13 0.12
PBH News
Prestige Consumer Healthcare Inc (PBH) Shares Fall 3.4% -- What GF Score of 70 Tells Investors
Oct 23, 2026 03:59 PM · gurufocus.com
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?
Oct 15, 2026 07:26 AM · zacks.com
Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results
Oct 14, 2026 04:30 AM · globenewswire.com
Amylyx's Avexitide Phase III Win Sets Up FDA Filing for PBH Treatment
Oct 02, 2026 11:03 PM · marketbeat.com
Best Value Stocks to Buy for October 1st
Oct 01, 2026 04:30 AM · zacks.com
PBH vs. NEOG: Which Stock Is the Better Value Option?
Sep 30, 2026 08:41 AM · zacks.com
More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds
Sep 30, 2026 05:18 AM · prnewswire.com
Premium Brands (TSE:PBH) Reaches New 52-Week Low – Here’s What Happened
Sep 25, 2026 12:23 AM · defenseworld.net
PBH or NEOG: Which Is the Better Value Stock Right Now?
Sep 14, 2026 08:40 AM · zacks.com
Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Sep 10, 2026 01:27 PM · seekingalpha.com